Maypro obtains exclusive U.S. distribution rights for Cannabid-ALL CBDA ingredient

Photo © AdobeStock.com/contentdealer

Maypro (Purchase, NY) has obtained exclusive U.S. distribution rights to a complete spectrum whole hemp CBDA extract called Cannabid-ALL. The ingredient is produced through a patented process by its supplier Extraordinary Extracts LLC, which is a division of American BioSciences. CBDA can be very difficult to produce, and extraction methods, such as CO2, cannot keep CBDA from decarboxylating into CBD. The extraction method used by Extraordinary Extracts not only maintains the CBDA content from the plant, but also preserves constituents of the plant flower, such as polyphenols and chlorophyll. According to the company, Cannabid-ALL provides the highest ratio of CBDA/CBD available.

“American BioSciences has enjoyed a business relationship with Maypro for more than 22 years and in that time we have always been able to count on them to provide us with the highest quality all-natural ingredients for our finished products,” said Rick Jahnke and Dave Wales, founders and owners of American BioSciences Inc., in a press release. “Now, we are extremely happy that we can provide our first-in-class ingredients to Maypro, a company that has an amazing reputation worldwide, for providing the best ingredients available.”

“At Maypro, we look for science-backed ingredients that meet a market need while offering something unique within the category,” said Denis Alimonti, director of U.S. Nutrition at Maypro. “American BioSciences and Extraordinary Extracts took on a saturated Hemp and CBD category and created a patented extraction technology to produce a unique, first-in-class ingredient that far surpasses any competition.”

Cannabid-ALL is the only hemp-based ingredient in Maypro’s proprietary and branded ingredients portfolio. It is non-GMO, gluten-free, sugar-free, dairy-free, soy-free, vegan, and available in bulk powder and oil, bulk capsules, bulk softgels, as well as private label finished bottles.